Psychopharmacology and Psychiatry Updates
305 episodes - English - Latest episode: 1 day ago - ★★★★★ - 232 ratingsPractical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Acute Agitation and Dexmedetomidine: A Novel Treatment Approach
August 30, 2023 16:00 - 8 minutes - 11.3 MBIn this episode, we delve into a new horizon in the management of acute agitation. We discuss dexmedetomidine, a drug that's been around since 1999, recently reformulated into a sublingual film and FDA approved for treating agitation associated with schizophrenia or bipolar I or II disorder. We explore the results from a recent randomized trial and its potential for transforming psychiatric care. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here ...
The Prevalence and Risks of RBD
August 25, 2023 16:00 - 10 minutes - 14.4 MBIn this episode, we dive into rapid eye movement sleep behavior disorder (RBD). Did you know that RBD's prevalence is on par with schizophrenia in middle-aged and older adults? Tune in as we explore the prevalence, assessment, and management of RBD, a condition that is not only a sleep disorder but a potential harbinger of severe neurological conditions, like Parkinson's Disease and Dementia with Lewy Bodies. Faculty: Carlos Schenck, M.D. Host: Richard Seeber, M.D. Learn more about our m...
ADHD Medication and Their Role in Anxiety and Depression
August 20, 2023 16:00 - 9 minutes - 13.5 MBIn this episode, we dive deep into the effects of ADHD medication on anxiety and depressive symptoms in children and adolescents. Can these medications significantly exacerbate symptoms of anxiety or depression? Or do these symptoms arise more from the underlying condition of ADHD? We will delve into these critical questions and more through a thorough exploration of a comprehensive meta-analysis. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership h...
In the Realm of Sleep: RBD Diagnosis Explained
August 15, 2023 16:00 - 8 minutes - 7.93 MBIn this episode, we delve deep into the diagnostic mysteries of RBD, the need for video polysomnography, and the mechanisms leading to RBD. Whether you are a veteran or new to the field, this episode promises to deepen your understanding of RBD. Faculty: Carlos Schenck, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Parasomnias Triggered by Antidepressant Medications: REM Sleep Behavior Disorder and Restless Legs Syndrome Diagnosing REM Sleep Beh...
NAC in Schizophrenia: Pie in the Sky or Groundbreaking Solution?
August 10, 2023 16:00 - 8 minutes - 11.3 MBAre we missing a vital piece in the schizophrenia treatment puzzle? In this episode, we explore the intriguing and controversial role of N-acetylcysteine (NAC) in schizophrenia. We dive deep into the evidence, the theories, and the ongoing debates about this seemingly simple over-the-counter supplement. Could NAC be the key to unlocking better outcomes for those with schizophrenia, or is it just another dead end? Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our m...
Child Psychiatry: NAC and SAMe
August 05, 2023 16:00 - 7 minutes - 10.1 MBHow can N-acetyl cysteine (NAC) and S-adenosyl methionine (SAMe) be effectively integrated into child and adolescent psychiatric treatment? In this episode, we dive deep into the world of NAC and SAMe and explore their potential applications, dosage, side effects, and more. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Natural Medications in Child and Adolescent Psychiatry Administration of N-Acetylcysteine and S-Adenos...
Youth Psychotropic Prescription Trends: Pandemic Influence
July 31, 2023 16:00 - 8 minutes - 11.4 MBHow has the use of antipsychotics among children and adolescents been affected by the COVID-19 pandemic in the United States? In this episode, we delve into pandemic-induced trends in youth psychotropic prescriptions. Uncover how COVID-19 reshaped mental health services and psychopharmacology among young individuals. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 07 Psychotropic Prescriptions in Youth...
Nature's Remedies in Youth: St. John's Wort and Valerian
July 26, 2023 16:00 - 13 minutes - 17.9 MBCan nature’s remedies hold the key to mental well-being in our youth? In this episode, we delve into the potential uses and limitations of St. John’s wort and valerian in child and adolescent psychiatry and, most importantly, their evidence in treating psychiatric disorders in this population. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Natural Medications in Child and Adolescent Psychiatry St. John’s Wort and Valeria...
Exploring Serotonergic Antidepressants for PMDD
July 21, 2023 16:00 - 10 minutes - 14.2 MBHave you ever pondered the mystery behind the effectiveness of different SSRI dosing strategies for premenstrual dysphoric disorder (PMDD)? In this episode, we delve deep into the complex world of PMDD treatments, focusing on the intriguing comparison between intermittent luteal phase dosing and continuous dosing of serotonergic antidepressants. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 46 Intermittent Sel...
Exploring Omega-3's Role in Child Psychiatry
July 16, 2023 16:00 - 14 minutes - 20 MBHave you ever wondered how natural remedies like omega-3 fatty acids might influence child and adolescent psychiatry? In this episode, we delve into the intriguing world of omega-3 fatty acids and their potential role in treating various psychiatric disorders in children and adolescents, such as major depressive disorder, bipolar disorder, ADHD, and ASD. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Natural Medications in...
ADHD Meds for Preschoolers: Lisdexamfetamine
July 11, 2023 16:00 - 8 minutes - 11.3 MBHave you ever wondered about the safety and effectiveness of ADHD medications in preschoolers? In this episode, we discuss a pioneering double-blind, fixed-dose study exploring the use of lisdexamfetamine in children aged 4–5 years. We delve into the nuances of this complex topic, from the increasing trend of psychotropic medication use in young children, to the unique characteristics that distinguish lisdexamfetamine from other amphetamine medications. Faculty: David Rosenberg, M.D. Hos...
Using Ginkgo Biloba in Children
July 06, 2023 16:00 - 9 minutes - 13.1 MBIn this episode, we delve into the intriguing world of ginkgo biloba and its potential role in treating ADHD in children and adolescents. Can this ancient herbal remedy offer a valuable alternative or adjunctive therapy? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Natural Medications in Child and Adolescent Psychiatry Use of Ginkgo Biloba in Children and Adolescents
Examining COVID's Lasting Effects in Psychiatry
July 01, 2023 16:00 - 9 minutes - 12.7 MBIn this episode, we delve into the intriguing world of COVID-19's long-term effects in psychiatry. We explore a groundbreaking study that examines the duration of COVID-associated psychiatric disorders and variations in susceptibility by age. How long do these disorders persist, and are certain age groups more affected? Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 46 Neurologic and Psychiatric Risk Trajectori...
Beyond SSRIs: Antipsychotic Augmentation in OCD
June 26, 2023 16:00 - 11 minutes - 15.1 MBIn this episode, you'll discover the preferred second-generation antipsychotics for augmenting treatment for obsessive-compulsive disorder: Risperidone and aripiprazole. We discuss their effectiveness and important considerations when choosing between them. What factors should clinicians weigh when deciding on an augmentation strategy? Faculty: David Osser, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Algorithm for the Pharmacotherapy of Obsessiv...
Overcoming Barriers to Metabolic Monitoring in Youth Treated With SGAs
June 21, 2023 17:50 - 11 minutes - 15.5 MBIn this episode, we focus on the challenges faced in metabolic monitoring of youth receiving second-generation antipsychotics (SGAs), including the strategies to overcome these barriers and ensure the long-term health of young patients on SGAs. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 06 Barriers to Metabolic Monitoring of SGAs in Youth
Exploring Outcomes and Strategies in OCD Treatment After the First Trial
June 16, 2023 16:00 - 11 minutes - 16.4 MBIn this episode, we delve into the potential outcomes after the first SSRI trial for OCD. With SSRIs being a first-line treatment, understanding response patterns is crucial. What course of action should be taken when patients exhibit significant symptom improvement, partial relief, or no response? Discover when to discontinue, switch, or augment treatment. Faculty: David Osser, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Algorithm for the Pharm...
Diving Into the APA Annual Meeting: Highlights and Insights!
June 11, 2023 16:00 - 16 minutes - 23 MBIn this episode, Dr. Richard Seeber and his special guests, Dr. Lorena Rodriguez and Dr. Paz Badia, discuss the topics covered in the APA Annual Meeting 2023, from technology in mental health practice to the use of cognitive–behavioral therapy for suicide prevention. Get ready to explore topics like ECT, ADHD, women's health, and much more. How can the integration of technology revolutionize mental health practice? Faculty: Paz Badia, M.D. and Lorena Rodríguez, M.D. Host: Richard Seeber,...
Exploring the Intriguing World of Microdosing Psilocybin
June 06, 2023 16:00 - 9 minutes - 12.4 MBIn this episode, we delve into the fascinating world of microdosing psilocybin. A recent randomized trial examined the effects of microdosing using various outcome measures. Surprisingly, the acute effects were significantly more intense for the active dose but only when participants correctly identified their experimental condition. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 45 Microdosing With Psilocybin ...
SSRIs for OCD: A Closer Look at First-Line Treatment
June 01, 2023 16:00 - 11 minutes - 15.4 MBWhat factors should clinicians consider when choosing an SSRI for treating patients with OCD? In this episode, we dive into the first-line treatment for OCD: SSRIs. Discover the most effective SSRIs for treating OCD, recommended doses, and potential adverse effects. Faculty: David Osser, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Algorithm for the Pharmacotherapy of Obsessive-Compulsive Disorder Node 2: First-Line Treatment: SSRIs
Exploring Nonstimulant Treatments for ADHD
May 27, 2023 16:00 - 10 minutes - 14.1 MBAre there any particular situations where nonstimulant medications may be especially effective for ADHD? In this episode, we discuss nonstimulant treatments for ADHD. Although stimulants are commonly used for ADHD, nonstimulant options like atomoxetine, viloxazine, clonidine, and guanfacine have been FDA approved and can be equally effective in certain populations. Listen in as we share clinical pearls on how to tailor treatments for each patient's unique needs. Faculty: David Rosenberg, M...
Complexities of OCD Treatment: Comorbidities and Other Considerations
May 22, 2023 16:00 - 10 minutes - 14.2 MBIn this episode, we share insights into the comorbidities and other considerations that can impact the treatment algorithm for OCD. From the risks of medication use in pregnant women, to the challenges of treating OCD in patients with comorbid bipolar disorder, this episode provides valuable clinical pearls for clinicians looking to improve their approach to treating OCD. Faculty: David Osser, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Algorith...
Lamotrigine and Lithium Combination Therapy for Rapid Cycling Bipolar Disorder
May 17, 2023 16:00 - 9 minutes - 12.9 MBIn this episode, we discuss rapid cycling bipolar disorder and its treatment, focusing on the use of the combination of lamotrigine and lithium. We also highlight the importance of checking thyroid status and tapering antidepressants in patients with rapid cycling. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 45 Lamotrigine and Lithium Combination for Treatment of Rapid Cycling Bipolar Disorder: Results From ...
Melatonin and Secretin for Youth
May 12, 2023 16:00 - 12 minutes - 16.9 MBIn this episode, we discuss the potential use of melatonin as a safe and effective pharmacotherapy for sleep disturbances in children with ADHD and ASD. Did you know that up to 80% of children with ASD experience sleep disorders? Listen in to learn how melatonin can help improve sleep onset and duration in these patients. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Atypical Psychopharmacologic Strategies for Children a...
Tackling NSSI in Adolescents: Can Medications Help?
May 07, 2023 16:00 - 8 minutes - 11.4 MBWhich medications are safe and effective for treating nonsuicidal self-injury (NSSI) in children and adolescents? In this episode, we discuss the use of psychotropic medications in treating NSSI, which is becoming increasingly common in this population and can predict future suicide attempts. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 05 Psychotropic Drugs for Treating Nonsuicidal Self‑Injury in t...
D-Cycloserine for Anxiety Disorders in Youth
May 02, 2023 16:00 - 14 minutes - 19.4 MBThis episode discusses D-cycloserine’s potential indications and administration in children and adolescents, including the evidence for anxiety disorders, OCD, ASD, and PTSD. It also mentions the dosage, administration, benefits, and side effects of D-cycloserine in youth. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Atypical Psychopharmacologic Strategies for Children and Adolescents D-Cycloserine: Potential Indicatio...
Clinical Significance of Antidepressants for the Treatment of Acute Depression
April 27, 2023 16:00 - 7 minutes - 10.8 MBAntidepressants are commonly used to treat depression, but how effective are they? In this episode, we discuss the concept of the minimal clinically important difference (MCID) and how it can be applied to assess antidepressant efficacy in treating depression. Specifically, knowing MCID estimates helps to shed light on recent controversies regarding antidepressant efficacy. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Ta...
Memantine: Potential Indications in Youth
April 22, 2023 16:00 - 12 minutes - 17.2 MBWhat is the role of memantine in pediatric populations? This episode discusses memantine’s potential indications and administration in children and adolescents, an explanation of the theory of glutamatergic dysregulation, and the evidence of memantine for ASD, OCD, and mood disorders. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Atypical Psychopharmacologic Strategies for Children and Adolescents Memantine: Potential I...
Low-Dose Olanzapine for Anorexia Nervosa
April 17, 2023 16:00 - 9 minutes - 13.5 MBIn this episode, we examine the tolerability, safety, and effectiveness of low-dose olanzapine in adolescents with anorexia nervosa (AN). Learn about the potential benefits and risks of using olanzapine in AN patients and the importance of a multidisciplinary approach in treating this challenging population. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 05 Low-Dose Olanzapine for Treating Adolescents...
Naltrexone in Youth: Exploring Potential Applications and Cautions
April 12, 2023 16:00 - 13 minutes - 18.2 MBIn this episode, we discuss the potential uses and challenges of naltrexone in children and adolescents while addressing the limited and conflicting evidence. We also examine the dosage, side effects, and important considerations for using naltrexone in young populations. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Atypical Psychopharmacologic Strategies for Children and Adolescents Naltrexone: Potential Indications a...
Lamotrigine Titration: Slowing Down for Safer Treatment
April 07, 2023 16:00 - 10 minutes - 14.3 MBWould a slower lamotrigine titration rate decrease the likelihood of developing the dreaded lamotrigine-associated rash? This episode discusses the possible advantages of slower lamotrigine titration rates, tips for managing benign rashes, and when to rechallenge lamotrigine. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 44 Impact of Selected Initial Titration Schedules on Safety and Long-Term Effectiveness of...
Using Benzodiazepines in Geriatric Patients
April 02, 2023 16:00 - 6 minutes - 9.39 MBIn this episode, we dive into a topic that's especially relevant for those working with older adults: The use of benzodiazepines and sedative-hypnotics. We explore the unique considerations of prescribing these medications to geriatric patients and the importance of deprescribing them when possible. Faculty: Lauren Gerlach, D.O. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Updates on Geriatric Psychopharmacology Considerations for Using Benzodiazepi...
Lithium Use in Pediatric Patients
March 28, 2023 16:00 - 12 minutes - 17 MBIn this episode, we delve into lithium's efficacy and potential long-term effects in younger patients and what clinicians should carefully monitor in this population. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 04 Long-Term Effects of Lithium Use on Children and Adolescents
Using Mood Stabilizers in the Geriatric Population
March 23, 2023 16:00 - 8 minutes - 11.3 MBAre mood stabilizers the right choice for elderly patients? This episode discusses key insights about using mood stabilizers in the geriatric population, including side effects and monitoring for lithium, valproic acid, lamotrigine, carbamazepine, and gabapentinoids. Faculty: Lauren Gerlach, D.O. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Updates on Geriatric Psychopharmacology Considerations for Using Mood Stabilizers in the Geriatric Population
Bright Light Therapy for Perinatal Depression
March 18, 2023 16:00 - 8 minutes - 11.5 MBDo you have a patient suffering from postpartum depression? In this episode, we discuss a new study on light therapy as a potential treatment for postpartum depression, including the response rate, adverse effects, and effects on sleep quality. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 43 Efficacy of Bright Light Therapy in Perinatal Depression: A Randomized, Double-Blind, Placebo-Controlled Study
Using SSRIs in the Geriatric Population
March 13, 2023 17:00 - 18 minutes - 24.9 MBThis episode discusses some strategies for starting antidepressants in the elderly, the important role of titrating doses, the efficacy of SSRIs, the side effects and drug–drug interactions of different medications, and clinical tips for using SSRIs and SNRIs in this population. Faculty: Lauren Gerlach, D.O. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Updates on Geriatric Psychopharmacology Using SSRIs and SNRIs in the Geriatric Population
Safety and Efficacy of Duloxetine in Youth With MDD
March 08, 2023 17:00 - 8 minutes - 11.6 MBIs duloxetine a viable option for youth with MDD? In this episode, we discuss the need for additional medication options in youth with depression as well as an RCT of duloxetine to assess its efficacy and a label extension trial to evaluate its long-term safety. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 04 Efficacy and Safety of Duloxetine in Children and Adolescents With MDD in Japan
Challenges in Prescribing Psychotropics to the Geriatric Population
March 03, 2023 17:00 - 7 minutes - 10.3 MBWhat are the most common challenges when prescribing psychotropics to older adults? This episode discusses the challenges in prescribing psychotropics to the geriatric population, such as poor medication adherence and the risks of inappropriate prescribing. It also introduces a clinical case and emphasizes the importance of medication reconciliation. Faculty: Lauren Gerlach, D.O. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Updates on Geriatric Psycho...
Antidepressants and Vertebral and Hip Risk Fractures
February 26, 2023 17:00 - 7 minutes - 10.5 MBIn this episode, we discuss an updated review of 11 studies that seek to evaluate the effect of antidepressants on the risk of hip and vertebral bone fractures. Although the overall effect size seems large, the absolute risk increase might be small. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 43 Antidepressants and Vertebral and Hip Risk Fracture: An Updated Systematic Review and Meta-Analysis
Antidepressants and Mood Stabilizers for Managing Explosive Behavior
February 21, 2023 17:00 - 6 minutes - 9.48 MBAre antidepressants effective for managing explosive behavior? In this episode, we discuss the efficacy of antidepressants and mood stabilizers for managing explosive behavior, including some proposed doses of lithium and divalproex sodium, and the indications for using antidepressants. Faculty: Carrie Vaudreuil, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Managing Explosive Behavior in Children and Adolescents Antidepressants and Mood Stabili...
Risk of Substance Use Disorders in Children Treated With Psychotropics
February 16, 2023 17:00 - 11 minutes - 15.6 MBIn this episode, we discuss a meta-analysis that included 6 million patients to assess whether pharmacotherapy increases the risk of substance use or misuse, specifically the risk of using stimulant medications in children with ADHD. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Smart Takes Vol. 03 Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders
FGAs and SGAs for Managing Explosive Behavior
February 11, 2023 17:00 - 8 minutes - 12.2 MBIn this episode, we discuss the SGAs with the most evidence for explosive behavior, their side effects, and monitoring recommendations. We also address the reasons for considering other SGAs and clarify which FGA has the most evidence for aggression. Faculty: Carrie Vaudreuil, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Managing Explosive Behavior in Children and Adolescents First- and Second-Generation Antipsychotics for Managing Explosive Be...
Use of Metformin to Prevent Clozapine-Induced Weight Gain
February 06, 2023 17:00 - 7 minutes - 10.5 MBShould we start prescribing metformin to our patients on clozapine? In this episode, we discuss several articles on the efficacy of clozapine in preventing clozapine-induced weight gain, including some evidence on when metformin is more effective. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 42 Metformin for the Prevention of Clozapine-Induced Weight Gain: A Retrospective Naturalistic Cohort Study
Managing Acute Aggression in Children and Adolescents
February 01, 2023 17:00 - 13 minutes - 18.1 MBIn this episode, we discuss the management of acute aggression in children and adolescents, including therapeutic support for explosive behavior, psychosocial crisis management techniques, and the medications used for acute aggression. Faculty: Carrie Vaudreuil, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Managing Explosive Behavior in Children and Adolescents Management of Acute Aggression in Children and Adolescents
Early Antipsychotic Nonresponse as a Predictor of Nonresponse
January 27, 2023 17:00 - 12 minutes - 17.2 MBIn this episode, we discuss whether early nonresponse in adolescents with first-episode psychosis predicts longer-term nonresponse and nonremission. We also explain when it is most likely that symptom improvement occurs and some other considerations when there is nonresponse. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 03 Early Antipsychotic Nonresponse as a Predictor of Nonresponse in Adolescents ...
Differential Diagnosis of Explosive Behavior
January 22, 2023 17:00 - 9 minutes - 12.6 MBIn this episode, we discuss the differential diagnosis of explosive behavior in children and adolescents, including the differences in these behaviors when they are associated with mood or anxiety disorders and disruptive behavior disorders. Faculty: Carrie Vaudreuil, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Managing Explosive Behavior in Children and Adolescents Management of Acute Aggression in Children and Adolescents
Long-Term Follow-Up of Schizophrenia in Youth
January 17, 2023 17:00 - 5 minutes - 8.07 MBIn this episode, we discuss the long-term follow-up of psychosis and schizophrenia in children and adolescents, including predictors of poor long-term outcomes and the comorbidities associated with schizophrenia in adults. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.5 CME: Publication Title Long-Term Follow-Up of Psychosis and Schizophrenia in Children and Adolescents
The Serotonin Theory of Depression
January 12, 2023 17:00 - 10 minutes - 14.1 MBIn this episode, we discuss a recent systematic umbrella review of the evidence behind the serotonin theory of depression and the controversy this review has generated. We explore the evidence presented regarding the interplay between serotonin and depression and present concrete steps to address several concerns generated by the review. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 42 The Serotonin Theory of ...
SSRIs and Type 2 Diabetes in Children and Adolescents
January 07, 2023 17:00 - 9 minutes - 13.5 MBIs there an association between SSRIs and type 2 diabetes in children and adolescents? In this episode, we discuss whether there is an association. We also explain whether there is an intraclass risk among different SSRIs. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Smart Take Vol. 02 SSRIs and Risk of Type 2 Diabetes in Children and Adolescents
Tips for Treating Schizophrenia in Children and Adolescents
January 02, 2023 17:00 - 7 minutes - 10.3 MBIn this episode, we discuss additional clinical tips for treating schizophrenia in children and adolescents, including the considerations for selecting antipsychotics, recommendations for nonresponse, and when to use clozapine. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.5 CME: Psychosis and Schizophrenia in Children and Adolescents Additional Clinical Tips for Treating Schizophrenia In Children and Adolescents
Physical Activity to Prevent Depression
December 28, 2022 17:00 - 10 minutes - 14.4 MBIn this episode, we review the current literature on the association between exercise and the risk for depression. Specifically, how much physical activity is associated with a lower risk for depression? We also discuss the World Health Organization recommendations for the ideal range of physical activity. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 41 Association Between Physical Activity and Risk of Depres...